Legislators
Bills
Statements
Lobbying
Travel
Searching...- Bills
- H.R.465
H.R.465: Prescription Drug Price Relief Act of 2019
About This Bill
- This bill was introduced in the 116th Congress
- This bill is primarily about health
- Introduced Jan. 10, 2019
- Latest Major Action Jan. 25, 2019
- See the one similar bills introduced in other congresses.
Bill Sponsor
Bill Cosponsors
22 (All Democrats)
Bill Version
- Introduced in House - Jan. 10, 2019
Bill Summary
Prescription Drug Price Relief Act of 2019 This bill establishes a series of oversight and disclosure requirements relating to the prices of brand-name drugs. Specifically, the bill requires the Department of Health and Human Services (HHS) to review at least annually all brand-name drugs for excessive pricing; HHS must also review prices upon petition. If any such drugs are found to be excessively priced, HHS must (1) void any...
(Source: Library of Congress)
Bill Actions
| Date | Description |
|---|---|
| Jan. 31, 2019 |
Referred to the Subcommittee on Health.
|
| Jan. 25, 2019 |
Referred to the Subcommittee on Health.
|
| Jan. 10, 2019 |
Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
|
| Jan. 10, 2019 |
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
|
| Jan. 10, 2019 |
Introduced in the House by Ro Khanna (D-Calif.) |